Skip to content

Effects of Gastric Bypass Surgery and Calcium Metabolism and the Skeleton

Effects of Gastric Bypass Surgery on Calcium Metabolism and the Skeleton

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01330914
Enrollment
55
Registered
2011-04-07
Start date
2011-07-31
Completion date
2015-01-31
Last updated
2019-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Bypass, Obesity, Morbid

Keywords

Obesity, Morbid, Bariatric Surgery, Gastric Bypass, Calcium Metabolism Disorders, Vitamin D, Bone Density, Body Composition, Weight Loss

Brief summary

Obesity is a chronic illness of staggering proportions. Because weight loss through diet and exercise is difficult to attain and maintain, there has been escalating interest in bariatric surgery, including Roux-en-Y gastric bypass. Gastric bypass surgery results in long-term weight loss, dramatic improvement in comorbidities such as diabetes, and decreased mortality. Emerging evidence suggests, however, that gastric bypass may have negative effects on bone health. Because of the serious consequences of osteoporosis and fracture, this is of great concern. This study of the effects of gastric bypass on calcium metabolism and the skeleton may positively impact the clinical care of gastric bypass patients by their surgeons, primary care providers, and endocrinologists. Further, the knowledge gained may inform future investigation into the relationships between obesity, weight loss, and bone biology.

Interventions

None listed

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
25 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

Scheduled to undergo gastric bypass surgery. Please note that to be eligible, one must already be working with a bariatric surgeon and with plans in place to undergo gastric bypass. This study is unable to arrange or pay for gastric bypass surgery.

Exclusion criteria

* Perimenopausal women * Known intestinal malabsorption * Prior bariatric surgery * Use of medications known to impact bone and mineral metabolism * Disease known to affect bone * Illicit drug use or alcohol use \>3 drinks/day * Serum calcium \>10.2 mg/dL * Calculated creatinine clearance \<30 mL/min * Weight \>350 pounds * Wrist circumference \>12 inches or calf circumference \>17 inches

Design outcomes

Primary

MeasureTime frameDescription
Change in Intestinal Calcium Absorption6 months (between baseline and 6 months)Change in fractional calcium absorption, determined by dual stable isotope method. Fractional calcium absorption is the fraction of ingested calcium that is absorbed, which is expressed here as the percentage of ingested calcium that is absorbed. The 6-month change is the mean difference in percentage absorption between time points. For example, if fractional calcium absorption were to decrease from 30% preoperatively to 25% at the 6-month postoperative time point, the change in fractional calcium absorption would be -5%.

Secondary

MeasureTime frameDescription
Areal Bone Mineral Density (BMD) at the Femoral Neck12 months post-operatively (between baseline and 12 months)Areal BMD at the femoral neck by dual-energy X-ray absorptiometry (DXA). The 12-month change is the percentage change between the 12 month and baseline time points.
Trabecular Number at the Tibia12 months post-operatively (between baseline and 12 months)Trabecular number at the tibia by high-resolution peripheral quantitative computed tomography (HR-pQCT). The 12-month change is the percentage change between the 12 month and baseline time points. HR-pQCT images were analyzed using the manufacturer's standard clinical evaluation protocol, with trabecular structure extracted using a threshold-based binarization process.

Countries

United States

Participant flow

Recruitment details

Women and men 25-70 years of age were recruited from two academic bariatric surgery centers (the University of California, San Francisco and the San Francisco Veterans Affairs Medical Center), where surgeons used the same standardized surgical approach to Roux-en-Y gastric bypass.

Participants by arm

ArmCount
Gastric Bypass Surgery Patients
Obese men and women undergoing gastric bypass surgery
55
Total55

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyNo longer eligible (sleeve gastrectomy)3
Overall StudyWithdrawal by Subject4

Baseline characteristics

CharacteristicGastric Bypass Surgery Patients
Age, Continuous45.8 years
STANDARD_DEVIATION 11.2
Body mass index44.2 kg/m2
STANDARD_DEVIATION 7
Diabetes status
Diabetic
22 participants
Diabetes status
Not diabetic
33 participants
Ethnicity (NIH/OMB)
Hispanic or Latino
6 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
49 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Femoral neck areal bone mineral density (DXA)0.949 g/cm2
STANDARD_DEVIATION 0.133
Menopausal status
N/A (Men)
11 participants
Menopausal status
Postmenopausal
14 participants
Menopausal status
Premenopausal
30 participants
Percentage body fat46.7 percentage of body fat
STANDARD_DEVIATION 5.9
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
3 Participants
Race (NIH/OMB)
Black or African American
12 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
2 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
37 Participants
Region of Enrollment
United States
55 participants
Sex: Female, Male
Female
44 Participants
Sex: Female, Male
Male
11 Participants
Spine volumetric bone mineral density (QCT)0.159 g/cm3
STANDARD_DEVIATION 0.036
Weight122.7 kg
STANDARD_DEVIATION 19.3

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
3 / 55
serious
Total, serious adverse events
1 / 55

Outcome results

Primary

Change in Intestinal Calcium Absorption

Change in fractional calcium absorption, determined by dual stable isotope method. Fractional calcium absorption is the fraction of ingested calcium that is absorbed, which is expressed here as the percentage of ingested calcium that is absorbed. The 6-month change is the mean difference in percentage absorption between time points. For example, if fractional calcium absorption were to decrease from 30% preoperatively to 25% at the 6-month postoperative time point, the change in fractional calcium absorption would be -5%.

Time frame: 6 months (between baseline and 6 months)

Population: Participants from the cohort who underwent assessment of fractional calcium absorption preoperatively and 6 months postoperatively

ArmMeasureValue (MEAN)Dispersion
Gastric Bypass Surgery PatientsChange in Intestinal Calcium Absorption-25.8 % of ingested calcium that is absorbedStandard Deviation 15.3
Secondary

Areal Bone Mineral Density (BMD) at the Femoral Neck

Areal BMD at the femoral neck by dual-energy X-ray absorptiometry (DXA). The 12-month change is the percentage change between the 12 month and baseline time points.

Time frame: 12 months post-operatively (between baseline and 12 months)

Population: participants who underwent DXA at pre-op and 12-month post-op time points

ArmMeasureValue (MEAN)Dispersion
Gastric Bypass Surgery PatientsAreal Bone Mineral Density (BMD) at the Femoral Neck-8.0 percent of baseline valueStandard Deviation 4.9
Secondary

Trabecular Number at the Tibia

Trabecular number at the tibia by high-resolution peripheral quantitative computed tomography (HR-pQCT). The 12-month change is the percentage change between the 12 month and baseline time points. HR-pQCT images were analyzed using the manufacturer's standard clinical evaluation protocol, with trabecular structure extracted using a threshold-based binarization process.

Time frame: 12 months post-operatively (between baseline and 12 months)

Population: participants who underwent HR-pQCT at pre-op and 12-month post-op time points

ArmMeasureValue (MEAN)Dispersion
Gastric Bypass Surgery PatientsTrabecular Number at the Tibia-4.6 percent of baseline valueStandard Deviation 8.4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026